DJIA 16,204.97 -211.61 -1.29%
NASDAQ 4,363.14 -146.42 -3.25%
S&P 500 1,880.05 -35.40 -1.85%
market minute promo

INSMED, INC. (NASDAQ: INSM)

12.78 -0.60 (-4.48%)

Quote as of


company name or ticker

Recent Quotes

INSM $12.78 -4.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.34
Previous Close $13.38
Daily Range $12.64 - $13.69
52-Week Range $12.32 - $28.66
Market Cap $789.9M
P/E Ratio -7.23
Dividend (Yield) $0.00 (0.0%)
Volume 705,693
Average Daily Volume 502,696
Current FY EPS -$2.01

Sector

Healthcare

Industry

Drug Makers

INSMED, INC. (INSM) Description

A biopharmaceutical company focused on the development and commercialization of drugs to treat metabolic diseases, endocrine disorders and oncology within niche markets that have unmet medical needs. Website: http://www.insmed.com/

News & Commentary

This Week in Biotech: A Double-Dose of Hot Potato

Two pharma giants walk away from collaborations, another investigational drug receives the breakthrough designation, and more M&A activity are this week's biggest biotech stories.

Thursday 2/4 Insider Buying Report: PGR, INSM

Commit To Buy Insmed At $10, Earn 14.5% Using Options

Insmed's (INSM) CEO Will Lewis on Q3 2015 Results - Earnings Call Transcript

Insmed (INSM) Q3 2015 Results - Earnings Call Webcast

H.C. Wainwright: Time To Buy Insmed

Leerink Chats With Biotech Management, Names 20 Stocks To Buy Now

Oversold Conditions For Insmed

Use Options For a Chance To Buy INSM at a 55% Discount

Insmed's (INSM) CEO Will Lewis on Q2 2015 Results - Earnings Call Transcript

Insmed (INSM) Q2 2015 Results - Earnings Call Webcast

See More INSM News...

INSM's Top Competitors

INSM $12.78 (-4.48%)
Current stock: INSM
AMGN $145.04 (-3.25%)
Current stock: AMGN
GILD $85.14 (-1.78%)
Current stock: GILD
BIIB $263.86 (-3.44%)
Current stock: BIIB